A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.

Source:http://linkedlifedata.com/resource/pubmed/id/19110224

Download in:

View as

Triples

General Info

PMID
19110224